AlloVir Inc. (ALVR)
NASDAQ: ALVR
· Real-Time Price · USD
9.81
0.39 (4.14%)
At close: Mar 18, 2025, 3:59 PM
AlloVir Revenue Breakdown
| Period Ending | Dec 31, 2020 |
|---|---|
| Grant Revenue | 900K |
| Grant Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.32M | 19.2M | 5.88M | 7.17M | 10.66M | 10.46M | 12.8M | 15.99M | 12.51M | 12.01M | 12.95M | 13.24M | 14.13M | 14.19M | 12.44M | 11.98M | 10.47M | 8.66M | 6.72M | 3.27M | 3M | 2.82M | 2.82M | 3.19M | 1.79M |
| Selling, General, and Administrative Revenue Growth | -77.48% | +226.43% | -17.94% | -32.76% | +1.89% | -18.28% | -19.94% | +27.82% | +4.15% | -7.20% | -2.26% | -6.24% | -0.47% | +14.07% | +3.87% | +14.40% | +20.91% | +28.89% | +105.57% | +8.90% | +6.49% | -0.18% | -11.50% | +78.51% | n/a |
| Research and Development Revenue | 6.03M | 320K | -246K | 93K | 12.17M | 33.23M | 34.16M | 31.31M | 30.72M | 27.33M | 30M | 31.38M | 29.07M | 41.6M | 33.06M | 25.68M | 20.39M | 16.76M | 17.18M | 8.88M | 6.84M | 6.69M | 5.66M | 2.75M | 1.15M |
| Research and Development Revenue Growth | +1784.38% | -230.08% | -364.52% | -99.24% | -63.37% | -2.71% | +9.09% | +1.93% | +12.41% | -8.93% | -4.38% | +7.95% | -30.13% | +25.83% | +28.76% | +25.91% | +21.70% | -2.47% | +93.38% | +29.92% | +2.27% | +18.25% | +105.26% | +139.36% | n/a |